Home » Topics » Regulatory

Regulatory
RSS

Combined AT1 antagonist and immunosuppressant for GvHD complications

July 31, 2000

Tetracyclines as a valuable and relatively safe therapy for corneal ulceration

July 31, 2000

New dosage form, indication approved for Bayer's cerivastatin

July 28, 2000

Abbot's divalproex newly formulated for once-daily dosing

July 27, 2000

Topically applied GAG synthesis inhibitors useful for corneal haze

July 27, 2000

Synergism reported by Aventis for combination chemotherapies

July 27, 2000

SmithKline Beecham submits sNDA for Paxil for use in PTSD

July 25, 2000

Fibrate/statin combinations claimed in recent patent literature by Bayer

July 24, 2000

Neuroprotective effects described for SB-269970

July 24, 2000

U.K. launch announced for Zyban

July 24, 2000

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 22, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 22, 2026.
Cell/gene therapy sector now sustainable; China competition mounting
BioWorld
There was an upbeat message for cell and gene therapy companies in the 2026 industry update presented as the J.P. Morgan Healthcare Conference opened on Monday,...
Abbvie snags PD-1/VEGF bispecific in potential $5B Remegen deal
BioWorld
With rumors regarding a couple of potential mega-mergers making the rounds, the week of the annual J.P. Morgan Healthcare Conference kicked off with the official...
Neurotrimin unveiled as marker in intellectual disability
BioWorld Science
Neurotrimin (NTM) is a member of the IgLON family, the disruption of which has been tied to emotional learning deficits and anxiety-like behavior in animal...